ONCOLOGY NURSE PRACTITIONERS AS PRINCIPAL INVESTIGATORS IN EARLY DRUG DEVELOPMENT CLINICAL TRIALS

被引：0
|
作者：
Jameson, Gayle [1 ]
Pelusi, Jody [2 ]
Rice, David [3 ]
Sharrah, Karen [4 ]
Burns, Kathleen [4 ]
Von Hoff, Daniel [1 ,5 ]
机构：
[1] HonorHealth, Scottsdale, AZ USA
[2] HonorHlth Res Inst, Scottsdale, AZ USA
[3] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[4] City Hope Natl Med Ctr, Duarte, CA USA
[5] Translat Genom Inst, Phoenix, AZ USA
来源：
ONCOLOGY NURSING FORUM | 2019年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
442
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Site Principal Investigators in Multicenter Clinical Trials Appropriately Recognizing Key Contributors
    Mentz, Robert J.
    Peterson, Eric D.
    CIRCULATION, 2017, 135 (13) : 1185 - 1187
  • [32] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Lauren A. Marcath
    Taylor D. Coe
    Emily K. Hoylman
    Bruce G. Redman
    Daniel L. Hertz
    BMC Cancer, 18
  • [33] Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials
    Marcath, Lauren A.
    Coe, Taylor D.
    Hoylman, Emily K.
    Redman, Bruce G.
    Hertz, Daniel L.
    BMC CANCER, 2018, 18
  • [34] Characteristics of Chief Investigators of Radiation Oncology Clinical Trials in Australia and New Zealand
    Nguyen, H.
    Montgomery, R.
    Sundaresan, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E142 - E142
  • [35] A Database of Drug Repurposing Clinical Trials in Oncology
    Pantziarka, Pan
    Vandeborne, Liese
    Bouche, Gauthier
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [36] Principal investigators over-optimistically forecast scientific and operational outcomes for clinical trials
    Benjamin, Daniel M.
    Hey, Spencer P.
    MacPherson, Amanda
    Hachem, Yasmina
    Smith, Kara S.
    Zhang, Sean X.
    Wong, Sandy
    Dolter, Samantha
    Mandel, David R.
    Kimmelman, Jonathan
    PLOS ONE, 2022, 17 (02):
  • [37] Development and influencing factors of compliance behaviors of investigators in clinical trials
    Yu-hong Shen
    Mao-zhong Li
    Xin-ping Zhang
    Zheng-qi Li
    Li-jun Wang
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2014, 34 : 284 - 288
  • [38] Development and influencing factors of compliance behaviors of investigators in clinical trials
    Shen, Yu-hong
    Li, Mao-zhong
    Zhang, Xin-ping
    Li, Zheng-qi
    Wang, Li-jun
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2014, 34 (02) : 284 - 288
  • [39] THE ROLE OF THE ONCOLOGY CLINICAL TRIALS NURSE (OCTN) IN RECRUITING MINORITIES AND PATIENTS WITH POOR PERFORMANCE STATUS TO ONCOLOGY CLINICAL TRIALS.
    Gansauer, Lucy
    Alexander, Kathryne
    Davila, Gitana
    Steele-Tilton, Angela
    Thomassie, Amy
    Castro, Kathleen
    ONCOLOGY NURSING FORUM, 2012, 39 (03) : E196 - E197
  • [40] DEVELOPMENT OF TREATMENT GUIDES AND A DRUG FORMULARY FOR NURSE-PRACTITIONERS
    WEST, S
    JOHNSON, R
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1973, 30 (04): : 316 - 320
12345